Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Bausch’s Duobrii Promos Censured For Excluding Risk Info, Making Misleading Superiority Claims
Apr 12 2022
•
By
Brenda Sandburg
US FDA objects to Bausch's promotions for its psoriasis lotion Duobrii. • Source: Alamy
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Marketing & Advertising
More from Compliance